Summary
In August 2024, New Zealand formally announced it would not adopt the revised Australia New Zealand Food Standards Code Standard 2.9. 1 – Infant Formula and decided instead to develop its own infant formula standard. The New Zealand Infant Formula Standard 2026 was officially published on 22 September 2026 and came into force on 25 September 2026, marking the formal implementation of New Zealand's dedicated infant formula standard.
The standard covers infant formula, follow-on formula and food for special medical purposes for infants. Infant formula is primarily for infants aged 0–6 months, while follow-on formula is primarily for infants aged 6–12 months. The new standard largely adopts most requirements of the latest revision of the Australia New Zealand Code Standard 2.9.
1, with adjustments only to provisions on protein source claims, nutrition information statements, the prescribed form of nutrition information statements and prohibited label claims, and adds a new section on 'permitted additional label claims'. The transition period runs from 25 September 2026 to 13 September 2029. During this period, infant formula sold in New Zealand may comply with either the 12 September 2024 version of the Australia New Zealand Code Standard 2.9.
1 or the New Zealand Infant Formula Standard 2026. From 14 September 2029, compliance with the new standard becomes mandatory, and the 12 September 2024 version will no longer serve as a basis for compliance. Key labelling differences include: food names must not include information about A2 beta-casein; voluntary claims of A1 or A2 beta-casein content are permitted, but total casein content must also be declared; and products declaring A1 or A2 beta-casein content must use the format prescribed in Schedule 1 of the new standard.
Commentary
The implementation of New Zealand's independent infant formula standard marks a substantive divergence in the joint Australia-New Zealand food standards system for infant formula. Fonterra, New Zealand's largest dairy company, has relatively high levels of A2 beta-casein in its raw milk. The new standard's allowance for voluntary A1/A2 beta-casein content claims provides a compliant pathway for differentiated marketing.
However, the prohibition on A2 information in food names may weaken the shelf appeal of some brands. For small and medium-sized New Zealand businesses relying on the Australian market, the dual compliance costs arising from Australia-New Zealand labelling differences warrant attention: a single product sold in both countries may require two sets of labels. The transition period runs until September 2029, giving companies ample time to adjust, but early adoption of the A2 claim format could provide a first-mover advantage.
As China is the largest export market for New Zealand infant formula, the new standard's regulation of A2 claims may affect Chinese consumer perceptions and, in turn, product strategies in cross-border e-commerce channels.
Keywords: infant formula standard, New Zealand, Australia New Zealand Food Standards Code, transition period, A2 beta-casein, nutrition information statement, label claims, 25 September 2026
AI illustration on MiDeer Observer
Source: foodmate.net
Disclaimer: This article is compiled from publicly available sources for general information only. The analysis and commentary are editorial opinions. MiDeer Observer does not guarantee the accuracy or completeness of the information provided. Readers should seek independent professional advice before relying on this content, or contact us for more information.






